🔗 Visit the ClinicalTrials.gov page for NCT00369226
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation. | J Clin Oncol | 2012 | 1.68 |
| 2 | Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors. | Blood | 2009 | 1.12 |
| 3 | Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review. | Biol Blood Marrow Transplant | 2009 | 0.78 |